Form 8-K - Current report:
SEC Accession No. 0001104659-23-042282
Filing Date
2023-04-06
Accepted
2023-04-05 18:36:22
Documents
14
Period of Report
2023-04-05
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2310981d1_8k.htm   iXBRL 8-K 30515
2 EXHIBIT 99.1 tm2310981d1_ex99-1.htm EX-99.1 237377
  Complete submission text file 0001104659-23-042282.txt   526817

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zura-20230405.xsd EX-101.SCH 3542
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zura-20230405_def.xml EX-101.DEF 27204
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zura-20230405_lab.xml EX-101.LAB 37236
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zura-20230405_pre.xml EX-101.PRE 25826
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2310981d1_8k_htm.xml XML 5354
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40598 | Film No.: 23803862
SIC: 2836 Biological Products, (No Diagnostic Substances)